# Anti-Inflammatory Effect of Aniba rosaeodora Essential Oil-Loaded Chitosan Membrane

**Authors:** Bruna Michele A. de B. Buriti, Caio Augusto de Almeida Canelas, Venâncio A. Amaral, Laine Celestino Pinto, Renata C. Silva, William N. Setzer, Tais Gratieri, Pablo Luis B. Figueiredo, Marcele F. Passos, Joyce Kelly R. da Silva

PMC · DOI: 10.1021/acsomega.5c06864 · 2026-02-18

## TL;DR

This study shows that chitosan membranes infused with Aniba rosaeodora essential oil have anti-inflammatory properties and could be used as wound dressings.

## Contribution

The novel contribution is the development of chitosan membranes with anti-inflammatory effects by incorporating Aniba rosaeodora essential oil.

## Key findings

- ArEO incorporation increased thermal stability and prevented essential oil degradation.
- Membranes with ArEO significantly reduced nitrite and TNF-α levels in inflammation models.
- ArEO-loaded membranes maintained mechanical properties suitable for wound dressing applications.

## Abstract

Bioactive chitosan
(CH) membranes containing 0.5, 2.5, and 5.0%
w/w of Aniba rosaeodora essential oil
(ArEO), rich in linalool (82.9%) and cis-linalool oxide (2.9%) were
developed using the casting method. Fourier transform infrared spectroscopy
(FTIR) results demonstrated that CH chains interacted with ArEO, leading
to increased thermal stability and preventing isolated ArEO degradation.
ArEO concentrations did not influence membrane morphology. Incorporating
ArEO into the formulated membranes did not significantly alter their
Young’s modulus (41.84–48.00 MPa), which remains within
the skin’s modulus of elasticity range (0.02 to 57 MPa). They
also exhibited mucoadhesion for tissue adhesion, with no significant
difference with adding ArEO (0.135–0.161 N). Additionally,
ArEO incorporated into the developed wound dressings significantly
reduced nitrite levels in the in vitro inflammation model. Tumor necrosis
factor-alpha (TNF-α) levels in lipopolysaccharide (LPS)-stimulated
macrophages were significantly reduced at all ArEO concentrations
in the wound dressings. The developed membranes may represent a promising
alternative for wound dressings with anti-inflammatory properties.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor)
- **Chemicals:** linalool (PubChem CID 6549), cis-linalool oxide (PubChem CID 6428573), chitosan (PubChem CID 129662530), nitrite (PubChem CID 946)
- **Species:** Aniba rosaeodora (taxon 1352902)

## Full-text entities

- **Genes:** Pla2g1b (phospholipase A2, group IB, pancreas) [NCBI Gene 18778] {aka Pla2a, sPLA2IB}, Pla2g5 (phospholipase A2, group V) [NCBI Gene 18784] {aka PLA2, PLA2-10, sPLA2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], Ly96 (lymphocyte antigen 96) [NCBI Gene 17087] {aka ESOP-1, MD-2, MD2}, Cd14 (CD14 antigen) [NCBI Gene 12475], Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Il17a (interleukin 17A) [NCBI Gene 301289] {aka CTLA-8, IL-17, IL-17A, Il17}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}
- **Diseases:** bacterial infection (MESH:D001424), oral cancer (MESH:D009062), diabetic (MESH:D003920), infection (MESH:D007239), blood loss (MESH:D016063), cytotoxic (MESH:D064420), loss (MESH:D016388), Inflammation (MESH:D007249), pain (MESH:D010146)
- **Chemicals:** citrulline (MESH:D002956), RNS (MESH:D011886), acetic acid (MESH:D019342), N-(1-naphthyl)ethylenediamine dihydrochloride (MESH:C008588), hydrogen (MESH:D006859), Carboxymethyl chitosan (MESH:C514968), Cellulose (MESH:D002482), polyvinylpyrrolidone (MESH:D011205), thymol (MESH:D013943), 2-nonanone (MESH:C026636), beta-phellandrene (MESH:C058582), calcium (MESH:D002118), citral (MESH:C007076), beta-pinene (MESH:C010789), citronellal (MESH:C108217), NO (MESH:D009569), DMSO (MESH:D004121), CO2 (MESH:D002245), peroxynitrite (MESH:D030421), alpha-pinene (MESH:C005451), CS (MESH:D002586), amide (MESH:D000577), tetrazolium salt (MESH:D013778), water (MESH:D014867), EO (MESH:D009822), azo dye (MESH:D001391), gamma-terpinene (MESH:C018669), Terpenoids (MESH:D013729), tea tree oil (MESH:D020947), LPS (MESH:D008070), Griess reagent (MESH:C095000), beta-myrcene (MESH:C008574), nitrogen (MESH:D009584), Nitrite (MESH:D009573), MTT (MESH:C070243), Dexamethasone (MESH:D003907), Polysaccharide (MESH:D011134), NO2 - (MESH:D009585), 3,3',5,5'-tetramethylbenzidine (MESH:C021758), poly(vinyl alcohol) (MESH:D011142), streptomycin (MESH:D013307), l-arginine (MESH:D001120), oil (MESH:D009821), monoterpene (MESH:D039821), polymer (MESH:D011108), saccharide (MESH:D002241), 2-undecanone (MESH:C526928), PVA (MESH:C063253), d-limonene (MESH:D000077222), curcumin (MESH:D003474), gold (MESH:D006046), carvacrol (MESH:C073316), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), platinum (MESH:D010984), camphene (MESH:C019286), O2 - (MESH:D013481), Aniba rosaeodora Essential Oil (-), alginates (MESH:D000464), penicillin (MESH:D010406), formazan (MESH:D005562)
- **Species:** Trypanosoma cruzi (species) [taxon 5693], Escherichia coli O111:B4 (no rank) [taxon 1090940], Cymbopogon citratus (lemon grass, species) [taxon 66014], Thymus pubescens (species) [taxon 497663], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Aniba rosaeodora (species) [taxon 1352902], Litsea cubeba (aromatic litsea, species) [taxon 155299], Leishmania infantum (species) [taxon 5671], Ruta graveolens (common rue, species) [taxon 37565]
- **Cell lines:** RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), L2630 — Homo sapiens (Human), Fanconi anemia, Finite cell line (CVCL_1M69)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961530/full.md

---
Source: https://tomesphere.com/paper/PMC12961530